Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from Cyclopharm Limited ( (AU:CYC) ) is now available.
Cyclopharm Limited has notified the ASX that director John William Wigglesworth ceased to be a director of the company effective 6 April 2026. In connection with his departure, the company disclosed that Wigglesworth holds 88,531 fully paid ordinary shares in Cyclopharm, with no additional indirect security holdings or interests in contracts reported.
The most recent analyst rating on (AU:CYC) stock is a Sell with a A$0.68 price target. To see the full list of analyst forecasts on Cyclopharm Limited stock, see the AU:CYC Stock Forecast page.
More about Cyclopharm Limited
Cyclopharm Limited is an Australian-listed company, though the notice does not specify its industry or core products. It is subject to ASX listing rules and Australian corporate disclosure requirements, including director interest reporting under the Corporations Act.
Average Trading Volume: 143,004
Technical Sentiment Signal: Sell
Current Market Cap: A$102.7M
For detailed information about CYC stock, go to TipRanks’ Stock Analysis page.